Universal Health Services, Inc. (UHS)

NYSE: UHS · Real-Time Price · USD

195.22

-1.94 (-0.98%)

At close: Nov 10, 2026, 4:00 PM EST

195.41

+0.19 (0.10%)

After-hours: Nov 10, 2026, 4:45 PM EST

Universal Health Services Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	11,255	13,622	11,836	10,405	10,060	10,421
Market Cap Growth	-21.42%	15.10%	13.74%	3.43%	-3.46%	-10.81%
Enterprise Value	17,262	18,748	16,917	15,755	15,207	14,396
Last Close Price	197.16	217.25	178.05	150.66	138.43	126.57

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	8.14	9.15	10.36	14.50	14.91	10.53
Forward PE	8.63	9.45	10.33	13.40	13.12	11.02
PS Ratio	0.61	0.78	0.75	0.73	0.75	0.82
PB Ratio	1.50	1.84	1.75	1.68	1.69	1.68
P/TBV Ratio	3.95	4.24	4.45	4.86	5.21	5.09
P/FCF Ratio	10.12	16.04	10.54	19.83	38.40	371.71
P/OCF Ratio	5.49	7.31	5.73	8.21	10.10	11.79
PEG Ratio	2.06	0.64	0.42	1.25	2.91	1.33

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	0.94	1.08	1.07	1.10	1.14	1.14
EV/EBITDA Ratio	6.52	7.18	7.46	9.04	9.26	7.47
EV/EBIT Ratio	8.68	9.40	10.06	13.40	14.33	10.33
EV/FCF Ratio	15.50	22.08	15.06	30.02	58.04	513.48

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.80	0.70	0.73	0.87	0.88	0.74
Debt / EBITDA Ratio	2.20	1.87	2.05	2.85	2.97	2.23
Debt / FCF Ratio	5.54	6.08	4.41	10.23	20.12	162.63
Net Debt / Equity Ratio	0.78	0.68	0.71	0.85	0.87	0.72
Net Debt / EBITDA Ratio	2.27	1.93	2.13	3.01	3.15	2.31
Net Debt / FCF Ratio	5.39	5.92	4.30	10.00	19.73	158.51
Asset Turnover	1.13	1.16	1.11	1.04	1.01	0.95
Inventory Turnover	44.07	43.01	41.59	39.68	38.73	38.22
Quick Ratio	1.11	0.85	1.04	1.17	1.11	0.94
Current Ratio	1.37	1.05	1.27	1.40	1.33	1.14
Return on Equity (ROE)	19.74%	21.33%	17.94%	11.82%	10.80%	15.67%
Return on Assets (ROA)	7.65%	8.31%	7.39%	5.35%	4.99%	6.56%
Return on Invested Capital (ROIC)	11.47%	12.72%	11.34%	7.96%	7.39%	10.64%
Return on Capital Employed (ROCE)	13.70%	16.20%	13.70%	9.80%	9.20%	12.60%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	12.28%	10.93%	9.65%	6.90%	6.72%	9.52%
FCF Yield	9.88%	6.23%	9.49%	5.04%	2.60%	0.27%
Dividend Yield	0.41%	0.36%	0.44%	0.52%	0.56%	0.59%
Payout Ratio	3.34%	3.44%	4.67%	7.73%	8.65%	6.64%
Buyback Yield / Dilution	6.83%	5.06%	3.18%	5.02%	11.78%	2.21%
Total Shareholder Return	7.24%	5.42%	3.62%	5.54%	12.34%	2.81%

SEC Filings: 10-K · 10-Q